Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384813 · ClinicalTrials.gov registry record · Phase 2
Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma
A Phase 2 study of Asthma, sponsored by Emory University.
- Completed
- Registry status
- Phase 2
- Development phase
- 43
- Enrollment target
- 2
- Study locations
NCT00384813 is a Phase 2 study of Asthma that has completed, run by Emory University. The registered enrollment target is 43 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT00384813, a Phase 2 study of Asthma, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 43 participants
- Enrollment target
- 2
- Study locations
Study Summary
Stress and anxiety can negatively affect children with asthma. Reducing the stress of asthmatic children and their families may lead to improved asthma care and fewer asthma symptoms in the children. The purpose of this study is to develop and evaluate a family-focused asthma education program aimed at reducing stress levels and improving asthma care for urban children with asthma.
Conditions Studied
Interventions
- BEHAVIORAL Project ASPIRE Home-Based Family Intervention
- BEHAVIORAL Project ASPIRE Enhanced Treatment As Usual
Study Locations (2)
Georgia
- Emory University School of Medicine - Atlanta
- American Lung Association - Southeast Division - Smyrna
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2007-01 |
| Est. Completion | 2009-04 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00384813
The ClinicalTrials.gov registry entry for NCT00384813 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (97% lower). The listed sponsor is Emory University, which has 1,208 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 2 interventions - of which Project ASPIRE Home-Based Family Intervention is the first listed.
NCT00384813 reports 2 study locations spanning 1 distinct geographic area - top geographies include Georgia.
Frequently Asked Questions
What is clinical trial NCT00384813 about?
NCT00384813 is a clinical study titled "Family-Focused, Stress-Reduction Program to Improve the Health Care of Urban Children With Asthma". Stress and anxiety can negatively affect children with asthma. Reducing the stress of asthmatic children and their families may lead to improved asthma care and fewer asthma symptoms in the children. The purpose of this study is to develop and evaluate a family-focused asthma education program aimed...
What is the current status of trial NCT00384813?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 43 participants. The study started on 2007-01. Estimated completion is 2009-04.
What conditions does trial NCT00384813 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00384813?
The interventions under investigation include: Project ASPIRE Home-Based Family Intervention (BEHAVIORAL), Project ASPIRE Enhanced Treatment As Usual (BEHAVIORAL).
Who is sponsoring clinical trial NCT00384813?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00384813 being conducted?
This trial has 2 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Escitalopram in Asthma Patients With Frequent Exacerbation
RECRUITING · Phase 2
-
Metformin IN Asthma for Overweight and Obese Individuals (MINA)
RECRUITING · Phase 2
-
Study of Lunsekimig (SAR443765) Compared With Placebo in Adults With High-risk Asthma
RECRUITING · Phase 2
-
ENV-294 for Moderate-to-Severe Asthma: A 12-Week Study in Adults
RECRUITING · Phase 2
-
A Study to Evaluate Brenipatide Compared With Placebo in Adult Participants With Uncontrolled Moderate to Severe Asthma
RECRUITING · Phase 2
-
Supplementing L-citrulline to Overweight Late Asthma oNset Phenotypes
RECRUITING · Phase 2
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.